Humana Inc. (NYSE:HUM) saw its share price drop to a 52-week low of $212.33, reflecting a steep 42.3% decline over the past year. Despite the pullback, the company’s price-to-earnings ratio of 15.75 ...

Humana is raising its full-year guidance after surpassing revenue expectations in the second quarter, the insurer announced ...

Humana lowered its full-year 2025 GAAP EPS guidance to approximately $13.77, down from $14.68. At the same time, it raised ...

What Happened? Shares of health insurance company Humana (NYSE:HUM) fell 3.2% in the morning session after the company lost a ...

U.S. equities were mixed at midday with the market reacting to a strong report on the U.S. economy while awaiting the Federal ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Humana raised its full-year outlook as it anticipates a smaller decline in Medicare Advantage membership than originally ...

Shares of health insurance company Humana (NYSE:HUM) jumped 4.9% in the morning session after the company reported ...

It’s a significant loss for the insurer, which sued the government late last year after its star ratings plummeted for 2025.

Humana could face $1 billion to $3 billion in losses next year, with the star ratings drop in its Medicare Advantage program.